QUINOXALINE COMPOUNDS

[Problem] Provided is a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. [Means for Solution] The present inventors have investigated a...

Full description

Saved in:
Bibliographic Details
Main Authors KAIZAWA, HIROYUKI, NOMURA, TAKAHO, YAMAMOTO, SATOSHI, KAMIJO, KAZUNORI, SEO, RYUSHI, YAMAMOTO, HIROFUMI, AZAMI, HIDENORI, SUGITA, MARI, TSUCHIYA, KAZUYUKI, KUBOTA, HIDEKI
Format Patent
LanguageEnglish
French
German
Published 09.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Problem] Provided is a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. [Means for Solution] The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like, and thus, have found that an imidazoquinaxaline compound or a triazoloquinoxaline compound has a PDE9-inhibiting action, thereby completing the present invention. The imidazoquinoxaline compound or the triazoloquinoxaline compound of the present invention has a PDE9-inhibiting action and can be used as an agent for preventing and/or treating storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.
Bibliography:Application Number: EP20100748823